Law360, New York (December 03, 2009, 6:32 PM ET) -- Sen. Herb Kohl, D-Wis., on Thursday proposed an amendment to the U.S. Senate health care legislation that would place limits on the pay-for-delay deals that brand-name drug manufacturers strike with generics makers in order to slow the market entry of generic competition to blockbuster drugs.
Sen. Kohl submitted S. 369, the Preserve Access to Affordable Generics Act, as a bipartisan amendment to the health care legislative package, a Congressional aide with knowledge of the amendment said.
The amendment, as modified in committee in September, would create...
Kohl Pitches Stricter Pay-For-Delay Drug Rules
To view the full article, take a free trial now.
